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Abstract
Background: The autoimmune thyroid diseases (AITD), including Graves’ disease (GD) and Hashimoto’s thyroiditis (HT),
are caused by interactions between susceptibility genes and environmental triggers. Single nucleotide polymorphisms
(SNPs) of Solute carrier family 22, member 4 (SLC22A4) have been shown to be associated with several autoimmune
diseases, including Crohn’s disease (CD) and rheumatoid arthritis (RA). The aim of this study is to investigate whether
SNP rs3792876 in the SLC22A4 gene is associated with GD, HT and AITD in a Chinese Han population.
Methods: In this study, we collected specimens from 553 Chinese Han individuals of 92 AITD pedigrees in 10 cities in
Liaoning province, China (80 GD pedigrees, 478 members; 12 HT pedigrees, 75 members). SNP rs3792876 was genotyped
using the TaqMan allelic discrimination assay. Hardy-Weinberg Equilibrium tests were performed among founders of the
pedigrees using Haploview software. Family-based association tests performed using FBAT software.
Results: No deviation from Hardy-Weinberg equilibrium was observed (p > 0.05). There were not significant association
between the SLC22A4 gene polymorphism (rs3792876) and GD, HT and AITD was found.
Conclusions: These results suggest a lack of association between the SLC22A4 gene polymorphism rs3792876 and
susceptibility to GD, HT and AITD in a Chinese Han population.
Background
The autoimmune thyroid diseases (AITDs) are com-
mon organ-specific autoimmune diseases with an esti-
mated prevalence of 1.5 % in general population [1].
They are characterized by infiltration of the thyroid with
thyroid reactive lymphocytes and lead to two clinically op-
posing manifestations: Hashimoto’s thyroiditis (HT) with
hypothyroidism and Graves’ disease (GD) affected by
hyperthyroidism [2]. As most autoimmune disorders,
AITD are complex conditions caused by interactions be-
tween genetic and environmental factors. Early family
studies indicated that up to 50 % of the siblings of patients
with AITD were thyroid antibody positive in contrast to ∼
15 % in the general population [3], suggesting a strong
genetic impact on the etiology of AITD. Since human
leukocyte antigen (HLA) loci were first associated with
GD [4], more than thirty chromosome regions [5] and a
number of immune-related genes [6, 7] have been impli-
cated in the genetic susceptibility to AITDs.
Among these genetic factors, the chromosome 5q31
region is of special interest because both our previous
GD family study [8] and a Japanese AITD affected sib-pair
study recognized 5q31 as an AITD susceptibility locus [9].
In addition, genetic variants in the 5q31 region have been
shown to be responsible for autoimmune related disor-
ders, such as Crohn’s disease (CD) [3], atopic dermatitis
(AD) [4] and bronchial asthma [5], by both classic genetic
linkage and powerful genome-wide association (GWAS)
studies. This chromosome region contains a cluster of
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cytokine and immune-related genes including IL4, IL13
and IRF1, suggesting a significant involvement of 5q31 in
human cytokine and autoimmune regulation [10, 11].
However, limited studies have been carried out to further
investigate the relationship between candidate genes in
5q31 and AITDs, which makes it still unclear of the
underlying mechanism for 5q31 genetic susceptibility to
AITDs.
The SLC22A4 gene is located on chromosome 5q31
and encodes the organic cation transporter OCTN1. It is
highly expressed in immune-related organs and tissues.
SLC22A4 mRNA expression is induced by proinflamma-
tory stimuli [12]. Genetic polymorphisms have been
found to affect SLC22A4 gene expression and to be asso-
ciated with autoimmune diseases such as rheumatoid
arthritis (RA),CD and type 1 diabetes (T1D) [12–14]. All
these findings suggest the essential role of SLC22A4 in
the autoimmune regulatory pathway. It maybe related to
autoimmune diseases in the development of auto-
immunity in secondary lymphoid organs [12]. Studies of
an intron 1 single nucleotide polymorphism (SNP)
rs3792876 in SLC22A4 showed that this polymorphism
affected binding of a transcription regulator, runt-related
transcription factor 1 (RUNX-1) [15, 16] and might
regulate the transcription of SLC22A4 [12]. Several other
recent publications have revealed that polymorphisms
affecting RUNX-1 binding sites may be associated with a
variety of autoimmune diseases such as psoriasis [15]
and systemic lupus erythematosus (SLE) [16]. Despite all
these evidences of involvement of SLC22A4 in human
autoimmune disease, the association of SLC22A4 with
AITD has never been studied. We hypothesized that
SLC22A4 might be involved in genetic susceptibility of
AITD through the transportation of small organic mole-
cules (such as immune regulatory factors), and such in-
volvement might be mediated by a SNP located in a
RUNX1-binding sequence in SLC22A4 affecting the ex-
pression of SLC22A4. In this study we collected AITD
pedigrees (GD pedigrees and HT pedigrees), genotyped
rs3792876 and assess the genetic susceptibility of this




In this study 92 Chinese Han AITD pedigrees (80 GD
pedigrees and 12 HT pedigrees) with 553 individuals
were recruited in Liaoning Province, China. Pedigrees
were ascertained through GD or HT probands at the
outpatient clinic of Department of Endocrine Diseases of
the First Hospital of China Medical University. Family
history was subsequently confirmed by at least one af-
fected first-degree family member. HT was diagnosed as
follows: 1) medical history or clinical biochemistry
evidence of hypothyroidism requiring thyroid hormone
replacement therapy, and 2) presence of autoantibodies
to thyroidperoxidase, with or without antibodies to
thyroglobulin. GD was diagnosed as follows: 1) medical
history or clinical biochemistry evidence of hyperthy-
roidism, 2) diffused goiter, and 3) the presence of at least
one of the following manifestations: positive thyroid
stimulating hormone (TSH) receptor antibody tests, dif-
fusely increased 131I (iodine-131) uptake in the thyroid
gland or presence of exophthalmos. All other family
members were classified as unaffected, whether their
thyroid autoantibody tests were positive or negative. All
diagnoses were made by at least two independent endo-
crine physicians. Research protocols were approved by
the medical ethics committee of the China Medical Uni-
versity and conformed to the guidelines set forth by the
Declaration of Helsinki. Written informed consents were
acquired from all of the participants or their guardians.
Peripheral venous blood samples were collected from all
of the participants for DNA preparations and biochem-
ical measurements.
Genotyping
Genomic DNA was isolated from peripheral white blood
cells using the DNA purification kit (QIAgen, Hilden,
Germany) according to the manufacturer’s instructions.
The rs3792876 SNP was genotyped by Taqman allelic
discrimination assay on a Roche LC480 Real-Time PCR
System (Roche Diagnostics, Penzberg, Germany). The
SNP was genotyped using a predesigned TaqMan SNP
Genotyping Assay (Applied Biosystems; assay ID
C_3170428_10). Amplification was performed in a total
of 10ul containing 30 ng of template DNA according to
the manufacturer’s standard program protocol. 5 % of the
samples were randomly chosen to confirm the genotypes
by direct sequencing for quality control.
Statistical methods
The Hardy-Weinberg Equilibrium was test among foun-
ders using Haploview4.2 [17]. Family-based association
tests (FBAT) were performed using the FBAT software
[18] (V2.0.3 Harvard School of Public Health, Depart-
ments of Biostatistics and Environmental Health, Pro-
gram for Population Genetics, Boston, Massachusetts,
USA). All of the tests were performed under the as-
sumption of an additive model, with a null hypothesis of
no linkage and no association. A P < 0.05 was considered
statistically significant. Differences in genotype fre-
quencies between patients and cases were calculated by
chi-square or Fisher’s exact test when necessary.
Result
Among 92 AITD pedigrees (553 individuals), 29 families
(32 %) had2patients, 39 (42 %) had 3and17 (18 %) had 4,
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5 (5 %) had 5 and 2 (2 %) had 6. Among the 80 GD ped-
igrees (478 individuals), 20 (25 %) had 1affected first-
degree relatives, 37 (46 %) had 2, 16 (20 %) had 3, 5
(6 %) had 4 and 2 (3 %) had 5. In total, there were 201
GD patients (45males and156 females; male/female ratio
of 1:3.47; mean age of 43.72 ± 14.31 years) and 277 first-
degree relatives (136 males and141 females, mean age of
48.95 ± 16.98 years). Among the 12 HT pedigrees (75
individuals), 9(75 %) had 1affected first-degree relatives,
2(17 %) had 2, and 1(8 %) had 3. There were 29 HT pa-
tients (8 males and 21 females, male/female ratio of
1:2.62, mean age of 42.45 ± 19.85 years) and 46 first-
degree relatives (18 males and 28 females, mean age of
47.55 ± 16.75 years). The patients’ general condition
was list in Table 1.
No deviation from Hardy-Weinberg equilibrium was
detected among all founders (P > 0.05). The genotyping
call rate was 99.6 % and the sequencing confirmation
rate was 100 %. In total, 80 GD, 12 HT and 92 AITD
pedigrees were genotyped for the SNP rs3792876. The T
allele frequency of rs3792876 was 21 % in GD pedigrees
and 20 % in AITD pedigrees. In addition, we performed
a FBAT; however, there was no significant association
detected (p > 0.05) (Table 2). We also compared the
genotype of rs3792876 in GD, HT and AITD patients
and controls, there was no significant association (p > 0.05)
(Table 3).
Discussion
Our previous study mapped a susceptible locus of GD in
chromosomal 5q31 regions [8]. A maximum LOD score
over 4 indicated a strong linkage between a GD pheno-
type and polymorphic genetic markers in this region.
We focused on this region in a subsequent study be-
cause this region contains many immune related genes
associated with autoimmune disorders or traits such as
CD, asthma, arthritis and T1D. We tested the linkage
between SNPs in 5q31 genes IL4, IL13, IRF1 and UGRP1
in Chinese GD patients [19]. However, a negative associ-
ation was observed.
In this study, we chose SLC22A4 as candidate gene
based on current knowledge on its molecular function
and genetic predisposition studies. SLC22A4 encodes an
organic cation transporter mainly expressed in the liver,
kidney, intestine and other organs. It is critical for the
elimination of many endogenous small organic cations
as well as a wide array of drugs and environmental
toxins. A functional intronic polymorphism rs3792876
has been studied in several different ethnic groups for an
association with immune disorders including CD, T1D and
RA. However, inconsistent results have been obtained. The
association of rs3792876 with RA was originally reported
in a Japanese population. The researchers suggested an
allelic difference of rs3792876 in affinity to RUNX1, a
transcriptional regulator in the hematopoietic system
[12]. This association was replicated in other Japanese
populations [20, 21] but not in Caucasian and Spanish
groups [22, 23]. The SNP rs3792876 was also shown to
genetically predispose patients to T1D [13] and CD [24].
However, these findings were never confirmed.
Before the current study, the association between
rs3792876 and GD, HT and AITD has never been
assessed. Our negative results may reflect the real condi-
tion that this variant may confer to limit or even no con-
tribution to etiology of GD, HT, and AITD. Although
previous studies suggested rs3792876’s involvement into
immune disorders, due to pathophysiological difference
between AITD and other autoimmune diseases, it’s
highly possible that SLC22A4 may be genetically totally
unrelated to GD, HT, or AITD.
Table 1 The clinical manifestation and biochemical characterization of GD, HT and AITD
GD pedigree HT pedigree AITD pedigrees
GD patients Controls HT patients Controls AITD patients Controls
Gender (M/F) 45/156 (1:3.47) 136/141 (1:1.04) 8/21 (1/2.62) 18/28 (1:1.56) 54/176 (1:3.25) 153/170 (1:1.11)
Age (year) 43.72 ± 14.31 48.95 ± 16.98 42.45 ± 19.85 47.55 ± 16.75 43.60 ± 15.17 48.40 ± 17.21
TSH (mIU/L) 0.10 (0.06-1.83) 1.26 (0.79-2.06) 2.04 (0.23-9.06) 2.45 (1.45-3.33) 0.23 (0.01-2.32) 1.37 (0.83-2.30)
FT4 (pmol/L) 25.81 ± 18.55 16.64 ± 3.07 18.79 ± 9.87 16.50 ± 2.01 24.91 ± 17.82 16.62 ± 2.94
FT3 (pmol/L) 7.58 ± 6.72 4.17 ± 0.89 4.71 ± 1.89 4.38 ± 0.97 7.21 ± 6.39 4.20 ± 0.90
TPOAb (IU/ml) 368.50 (46.85-1000) 10.10 (10.00-29.20) 1000.00 (458.75-1000.00) 10.60 (10.00-158.50) 503.50 (53.13-1000.00) 10.10 (10.00-33.35)
TgAb (IU/ml) 59.95 (20.00-460.00) 20.00 (20.00-94.70) 80.60 (31.18-3000.00) 20.00 (20.00-45.70) 59.95 (20.00-519.50) 20.00 (20.00-20.00)
Table 2 FBAT analysis of the association between GD, HT and
AITD and rs37928
Disease Family S-E(S) Var(S) Z P
GD 39 1.40 34.91 0.24 0.813
HT 1 - - - -
AITD 40 0.65 35.47 0.11 0.913
Family: Number of families that are actually informative for the test. S: test
statistics for the observed number of transmitted alleles. E(S): expected value
of S under the null hypothesis (i.e., no linkage or association)
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Potential limitations of this study must also be ad-
dressed. First, the sample size of our study is relatively
small, which may not have the efficient statistical power
to detect a weak genetic effect, resulting in a fluctuated
estimation. Second, we evaluated association of only one
common polymorphism of SLC22A4 gene with suscepti-
bility to GD, HT and AITD, there might be still other
unidentified SNPs which could influence the develop-
ment of GD, HT or AITD. Third, our pedigrees are all
Han Chinese. Genetic background is a very important
issue in genetic association study and may affect both
association strength and direction. Rs3792876 allelle fre-
quencies differ greatly among different ethnic groups
with highest MAF in East Asian (>0.2) and much lower
in other populations (<0.1). Therefore, more studies with
larger sample size, multiple ethnic groups and more
candidate genes are needed to further study the mo-
lecular genetic basis underlying chromosome region
5p31 in predisposition to GD, HT and AITD.
Conclusion
In this study we assessed the association of SLC22A4 gene
polymorphism rs3792876 with Chinese Han GD, HT and
AITD patients, our results suggested lack of association
between rs3792876 and GD, HT and AITD in the Chinese
Han population.
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